bioreactor

(redirected from Bioreactors)
Also found in: Dictionary, Medical.

bioreactor

[′bī·ō·rē‚ak·tər]
(biochemistry)
A vessel that is used for the fermentation and production of living organisms, such as bacteria or yeast.
McGraw-Hill Dictionary of Scientific & Technical Terms, 6E, Copyright © 2003 by The McGraw-Hill Companies, Inc.
References in periodicals archive ?
Wiseguyreports.Com Adds "Membrane Bioreactors -Market Demand, Growth, Opportunities and Analysis Of Top Key Player Forecast To 2024" To Its Research Database
[ClickPress, Tue Mar 26 2019] The growth of bioreactors in Pharmaceutical Sector and technological advancements in bioreactors, and adoption of single-use bioreactors (SUBs) and hybrid bioreactors are the prime factors responsible for the growth of the bioreactor market currently.
Sartorius Stedim Biotech (SSB) has launched the BIOSTAT RM TX single-use bioreactor, a new wave mixed system developed specifically for closed, automated expansion of consistent quality cell products such as ex vivo cellular immunotherapies.
The 4,000L CSR is the largest single-use bioreactor size available in the industry and potentially largest-ever design in conventional disposable bioreactors, resulting in higher productivity and significantly lowering the cost of goods for cell culture-based biopharmaceuticals.
This method is cumbersome and requires large facilities that are expensive and with limited scalability compared to animal cell cultures that can be propagated in large scale bioreactors for massive vaccine production [23].
Stirred Tank Bioreactor. The stirred bioreactors, well characterized and widely used for microbial and animal cell cultures, have been used to avoid the limitations of static culture.
Their topics are a novel see-saw bioreactor; simulating bioprocess and the development of BIPROSIM, a general purpose simulation program; the dynamic optimization of a bioprocess using a genetic algorithm; bioprocesses and time delay control; experimentation on the bioreactors; and the future scope of research.
Teresita Fortuna, DOST-NCR regional director, told the Manila Bulletin the DOST had already deployed 74 bioreactors nationwide as of Dec.
Similar bioreactors could enable researchers to study the behavior of new bone marrow drugs.
LONDON, U.K., November 27, 2014 -- There is widespread optimism that the single-use bioreactors market is likely to continue its double digit growth in the future.
* Seventeen manufacturers offering around 8090 models of single-use bioreactors with working volumes ranging from as low as few milliliters to up to 2000L.